| Product NDC: | 60951-735 |
| Proprietary Name: | Mycophenolate Mofetil |
| Non Proprietary Name: | mycophenolate mofetil |
| Active Ingredient(s): | 500 mg/1 & nbsp; mycophenolate mofetil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60951-735 |
| Labeler Name: | Qualitest Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090606 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100719 |
| Package NDC: | 60951-735-70 |
| Package Description: | 100 TABLET in 1 BOTTLE (60951-735-70) |
| NDC Code | 60951-735-70 |
| Proprietary Name | Mycophenolate Mofetil |
| Package Description | 100 TABLET in 1 BOTTLE (60951-735-70) |
| Product NDC | 60951-735 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mycophenolate mofetil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100719 |
| Marketing Category Name | ANDA |
| Labeler Name | Qualitest Pharmaceuticals |
| Substance Name | MYCOPHENOLATE MOFETIL |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |